Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration

• Published in: The oncologist (Dayton, Ohio) Vol. 28; no. 7; pp. 575 - 583
• Main Authors: Das, Satya, Stockton, Shannon S, Hassan, Saamir A
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 01.07.2023
• Subjects: Carcinoid; Carcinoid Heart Disease - diagnosis; Carcinoid Heart Disease - therapy; Carcinoid Tumor - drug therapy; Care and treatment; Development and progression; Diagnosis; Endocrinology; Everolimus - therapeutic use; Heart diseases; Humans; Malignant Carcinoid Syndrome - drug therapy; Neuroendocrine Tumors - drug therapy; Neuroendocrine Tumors - therapy; United States; 5-hydroxyindoleacetic acid; carcinoid syndrome; N-terminal pro B-type natriuretic peptide; carcinoid heart disease; neuroendocrine tumors

Abstract Carcinoid heart disease (CaHD) is an important complication among patients with metastatic neuroendocrine tumors and carcinoid syndrome (CS). CS patients (25%-65%) eventually develop CaHD; these patients face a significantly increased risk of morbidity and mortality. Guidance papers (eg, cl...